UnitedHealth Group faces real PBM reform risks, but legal paths, financials, and market pricing suggest opportunity in ...

President Donald Trump's drug pricing order seeks to balance innovation with affordability, ending the burden on American patients and ensuring fair global contributions.

The federal government and policy experts say potential impacts from Trump's order, including supply shortages and higher ...

US President Donald Trump has signed an executive order aimed at lowering the cost of prescription drugs. The plan could have ...

The new test, from Fujirebio Diagnostics, Inc., identifies a sticky brain plaque, known as beta-amyloid, that is a key marker ...

KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a ...

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said ...

Hospital groups are celebrating a federal judge’s initial ruling against pharmaceutical makers who contended a government ...

Septerna's GPCR platform shows promise, but execution risks, funding needs, and competition suggest caution. Click here to ...

“This is the first step towards the use of gene editing therapies to treat a wide variety of rare genetic disorders for which ...

The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release ...